Our Webinars

Our Webinars

An Overview & Comparison of US and EU Pediatric Drug Development Regulations and Processes

x

Synteract Pediatric Clinical Trial Leadership

Lynne Georgopoulos
VP, Pediatric Development Americas

Lynne Georgopoulos is an innovative, results-oriented, entrepreneurial-spirited biopharmaceutical executive with 25 years of experience in clinical operations/development, regulatory affairs, project management, and quality assurance. Lynne is a strong contributor to the leadership and team building of KinderPharm. Lynne manages the Clinical and Regulatory departments of KinderPharm as well as cross-functional groups, both internally and externally to meet aggressive development timelines. Lynne received a Master of Science in Health Sciences (MSHS) in Regulatory Affairs from The George Washington University and is regulatory affairs certified through the Regulatory Affairs Professional Society.

Contact us to find out more about our Pediatric expertise and experience
x

Synteract Pediatric Clinical Trial Leadership

Martine Dehlinger-Kremer
VP, Pediatric Development Europe

  • 30+ years of experience
  • Chair, EUCROF Pediatric Working Group
  • Chair, European Forum for Good Clinical Practice Children’s Medicines Working Party
  • Member, Enpr-EMA working groups, European Network of Pediatric Research at EMA
  • Participated in 100+ NDAs/MAAs and numerous clinical studies
  • PharmaVoice 100 recipient
Contact us to find out more about our Pediatric expertise and experience

An Overview & Comparison of US and EU Pediatric Drug Development Regulations and Processes

Date: Thursday, May 23, 2019
Time: 11am EDT(NA) / 4pm BST (UK) / 5pm CEST (EU-Central)
Length: 75 minutes

REGISTER

The evolution of pediatric guidance and regulations in the US and EU has had a positive impact on fostering research and generating new treatment options for pediatric patients over the past decade. However, navigating emerging requirements can be challenging. This webinar will provide an overview of key pediatric regulations and guidelines for development of pediatric drugs in US and European markets from two speakers with extensive, global knowledge in this area. Read more...

Presenters:



Looking for a previous webinar? Go to our Webinars Archive arrow
x

Submit RFI / RFP

..
By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Contact Synteract

Tell us how to stay in touch with you:

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Synteract Neuro Degenerative Clinical Trial Leadership

Linda RawlingsContact us to find out more about our Neuro Degenerative expertise and experience

Linda Rawlings, MSc, FIBMS
VP Neuro Degenerative Development

Contact us to find out more about our Neuro Degenerative expertise and experience
x

Synteract Rare and Orphan Diseases Clinical Trial Leadership

Lisa DilworthContact us to find out more about our Rare and Orphan Diseases expertise and experience

Lisa Dilworth
VP Rare and Orphan Diseases

Contact us to find out more about our Rare and Orphan Diseases expertise and experience
x

 

x

Download Resource

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required